22. Chronic Pain / Muscle Tension in ADHD
Author: Ulrich Brennecke
Review (March 2024): Waldemar Zdero, M.A. in Psychology
Completely revised: December 2024
Monoamines—specifically dopamine, norepinephrine, and serotonin—play a key role in pain regulation.1
1. Chronic Pain and ADHD
People with ADHD often exhibit increased sensitivity to pain. High ADHD scores correlated with increased pain.23 4 5 Children with ADHD have a 45% increased risk of weekly pain. Hyperactivity/impulsivity was associated with a 133% increased risk of frequent pain, while inattention was associated with a 17% increased risk. Multiple pain complaints were more common among girls with hyperactivity than among boys with hyperactivity (51.4% versus 27.9%). 25% of girls with ADHD-C and 20% of boys with ADHD-C experienced weekly headaches and/or abdominal pain, compared with 11 to 13% of children without these symptoms (+127% to +53%).6
Suffer from chronic pain
- Children and adolescents with ADHD
- between 66.9% and 29.1% (meta-analysis, k = 11)7
- often musculoskeletal or multisegmental
- Pain occurring at least once a week for more than 3 months
- Treatment with stimulants reduced the rate of chronic pain
- 20.8% (meta-analysis, k = 19, n = 1,043,878)8
- The prevalence rates of chronic pain among children and adolescents reported in a meta-analysis varied considerably:10
- Headaches: 8% to 83%
- Abdominal pain: 4% to 53%
- Back pain: 14% to 24%
- Skeletal muscle pain: 4% to 40%
- multiple pain symptoms: 4% to 49%
- Other types of pain: 5% to 88%.
- 20%11
- between 66.9% and 29.1% (meta-analysis, k = 11)7
- Adolescents and young adults
- 66.5% (9-year longitudinal study, n = 263 with ADHD, n = 8,200 controls) vs. 44.5% among the controls12
Similar symptoms include increased sensitivity to stress and increased sensitivity to punishment. See “Emotional Dysregulation” for more information.
Girls experience chronic pain more frequently than boys, except for back pain and skeletal muscle pain (meta-analysis, k = 19, n = 1,043,878).8
Of 100 women with ADHD or ASD, 76% reported chronic pain.13 In ADHD, chronic widespread pain (CWP)—the main symptom of fibromyalgia—was nearly twice as common (39%) as in ASD.
The most commonly reported areas of the body where people experienced pain were
- lower back (47%)
- Neck (37%)
- Shoulder (35%)
- Head (32%, based on ADHD)
- Stomach (30%)
- Arms / Hands (30%)
- upper back (27%)
- Knee (27%)
- Hips / Thighs (18%)
- Calves / Feet (16%)
- Breast (4%)
ADHD is associated with an increased incidence of14
- Fibromyalgia15
- chronic lower back pain16
- idiopathic orofacial pain 17
- chronic abdominal pain13
- Burning-Mouth Syndrome
- 92.2% of people with burning mouth syndrome had ADHD18
It is possible that chronic pain is more likely to be a cause of ADHD than ADHD is of chronic pain. There is significant genetic overlap between chronic pain and ADHD.19
Pain is associated with reduced tonic dopamine firing, which leads to increased phasic dopamine firing in the nucleus accumbens.20 This is consistent with the model developed by Grace, which posits reduced tonic and increased phasic dopamine firing in ADHD. See also Tonic and Phasic Dopamine in Explanatory Models for ADHD in the section Dopamine In the chapter Neurological Aspects.
People with chronic pain exhibit reduced responsiveness within the mesolimbic dopamine system to significant stimuli, lower D2 receptor binding, and reduced presynaptic dopamine activity in the striatum at rest and following an acute pain stimulus.21 In animals, chronic pain leads to reduced c-Fos activation in the VTA, decreased total dopamine levels, and a reduction in D2 receptors in the striatum.21
Conversely, a reduction in dopamine in the brain caused by acute depletion of the dopamine precursors phenylalanine and tyrosine resulted in increased subjective pain sensitivity (the degree to which pain was perceived as unpleasant) without altering sensory pain perception.22
In 6-OHDA mice, in which dopamine synthesis is chemically disrupted and which therefore serve as an animal model for ADHD, increased pain sensitivity was observed. This pain sensitivity was likely mediated by α- and β-adrenergic receptors as well as D2/D3 receptors. Atomoxetine23, like MPH24, was able to reduce the increased pain sensitivity associated with ADHD.
Stimulation of the substantia nigra, one of the brain’s two main sources of dopamine, alleviates pain by activating spinal cord neurons via dopaminergic signaling pathways.2526 27 Painful stimuli trigger a release of dopamine in the dorsolateral striatum, which correlates with the subjective perception of pain intensity. Similarly, the ventral striatum is clearly linked to the emotional dimension of the human pain process and to the anticipation of pain.28
Increased sensitivity to pain correlated with certain dopaminergic gene variants (DAT1 and MAO-A, but not DRD4).29
Increasing pain in children could be a precursor to restless legs syndrome. Serotonergic dysfunction, iron deficiency, and vitamin D deficiency could be common causes.30 Both conditions and all three of the aforementioned causal pathways are closely linked to ADHD.
Among children with chronic pain (excluding headaches), the prevalence of ADHD was found to be 15 to 25 percent—a 2- to 5-fold increase (meta-analysis).7
72.5% of adults referred to a pain clinic for chronic pain and a probable somatic syndrome disorder met the diagnostic criteria for ADHD.31 Of 60 adults with chronic nonspecific lower back pain, 31.5% had ADHD.16
Psychiatric patients with chronic pain have a higher prevalence of ADHD than psychiatric patients without chronic pain.9
Among young women with ADHD and/or ASD, 76.6%13 and 75.9%, respectively, reported chronic pain, compared with 45.7% of young women without these conditions12.
80% of the people with ADHD who were surveyed reported chronic pain.32
A 15-year population-based study found that children with ADHD were significantly more likely to experience various types of pain prior to their ADHD diagnosis:33
- Headaches (+16%)
- Earaches (+30%)
- Sore throat (+8%)
- Sprains and strains (+23%)
- more frequent use of pain relievers
- Acetaminophen (+19%)
- Ibuprofen (+37%)
A study found ADHD in 25 of 30 patients with refractory orofacial pain (83.3%; 20 of whom were women).34
ADHD was associated with a 32% increased risk of migraine, while the risk of tension-type headaches remained unchanged.3536 Children with migraine had a 2.6-fold risk of ADHD, while the prevalence of migraine among children in general was 3.76%. Migraine correlated specifically with hyperactivity and impulsivity, but not with inattention.37 Children with ADHD had a 2.6-fold risk of migraine, with the prevalence of migraine among children generally standing at 9.9% in this study.36
In Parkinson’s disease, which is also characterized by a dopamine deficiency, 30 to 50 percent of people with ADHD suffer from increased pain sensitivity.38 This can be alleviated with dopaminergic medication39, such as levodopa or deep brain stimulation.40
Conversely, in schizophrenia—which is associated with elevated dopamine levels—pain perception is reduced.41
The SHR ADHD animal model exhibits a dysregulated noradrenergic pain inhibition system.
In SHR, gabapentin was ineffective for neuropathic pain caused by segmental spinal nerve ligation, whereas duloxetine was effective.42 In Wistar rats, both gabapentin and duloxetine alleviated neuropathic pain. Unlike gabapentin, duloxetine increases spinal norepinephrine independently of locus coeruleus activation. Accordingly, norepinephrine reuptake inhibitors may be helpful for chronic pain associated with ADHD.
2. Axial Pain and ADHD
Chronic pain in patients with ADHD is characterized by widespread and axial pain that begins early in life. This “ADHD pain” differs qualitatively from chronic pain in patients without ADHD.9
Axial pain occurred in 86.6% of people with ADHD, in 50% of people without a diagnosis of ADHD, and in 21.4% of people who did not have subclinical ADHD either.
People with subclinical ADHD exhibited the same muscular dysregulation as people with ADHD.9
While ADHD is a predictor of “axial pain,” affective disorders, anxiety disorders, and personality disorders were not.9
The axial muscles are:
- Head and neck muscles
- Spinal muscles
- Other trunk muscles
- Pelvic floor muscles
Axial muscles regulate and control posture and are constantly working to maintain the inherently unstable upright position. Muscular dysregulation has significant effects in this area and could lead to high muscle tone, resulting in widespread pain and lower back pain.43
- Erector spinae
- Latissimus dorsi
- Iliopsoas
- connects the lumbar spine to the lower extremities
- Tightness in the iliopsoas muscle can exacerbate lumbar lordosis and lower back pain44
Gene variants associated with neck or shoulder pain causally increase the risk of ADHD.45
3. Medications for Chronic Pain
See the following section Chronic Pain Comorbid with ADHD on the page Choosing a medication for ADHD or ADHD with comorbid conditions In the chapter Treatment
4. Increased Muscle Tension in ADHD
ADHD is often accompanied by increased muscle tension. However, this is not a manifestation of hyperactivity or a fundamental motor dysfunction. There are elite athletes with ADHD; it is unlikely that they suffer from any serious motor dysfunction. Nevertheless, increased muscle tension can also be observed in these individuals.
Muscle tension, particularly in the shoulder and neck area, occurs significantly more often in people with ADHD.
An orthopedic surgeon explained to us that during sleep, the muscles farther from the trunk (spine) relax first, while those closest to the spine relax last. These muscles require undisturbed deep sleep in order to relax. Accordingly, muscle tension could also be a consequence of the sleep disturbances associated with ADHD.
A study found that computer use and sleep problems were correlated with chronic shoulder and neck pain.46
5. Pathways Leading to Chronic Pain, Increased Muscle Tone, and Fibromyalgia
According to Stray, motor disinhibition and increased muscle tone in ADHD are directly associated with dysregulation of the dopamine and norepinephrine systems.47
This is consistent with the fact that, in ADHD, methylphenidate reduces increased muscle tone48 and that a norepinephrine reuptake inhibitor (orphenadrine, Norflex®) acts as a skeletal muscle relaxant. Norepinephrine reuptake inhibitors are also used as ADHD medications (atomoxetine, viloxazine).
For more on this, see Chronic Pain and Muscle Tension in ADHD—Neurophysiological Correlates
Azizi SA (2022): Monoamines: Dopamine, Norepinephrine, and Serotonin, Beyond Modulation, “Switches” That Alter the State of Target Networks. Neuroscientist. 2022 Apr;28(2):121-143. doi: 10.1177/1073858420974336. PMID: 33292070. REVIEW ↥
Stickley, Koyanagi, Takahashi, Kamio (2016): ADHD symptoms and pain among adults in England. Psychiatry Res. 2016 Dec 30;246:326-331. doi: 10.1016/j.psychres.2016.10.004. ↥
Brown PCM, Feldstein Ewing SW, Wilson AC (2025): ADHD (Attention-Deficit Hyperactivity Disorder) Symptoms Are Associated With Chronic Pain Interference: Results From a Prospective Cohort Study. Child Care Health Dev. 2025 Jan;51(1):e70016. doi: 10.1111/cch.70016. PMID: 39629884; PMCID: PMC12051463. ↥
Kasahara S, Yoshimoto T, Oka H, Sato N, Morita T, Niwa SI, Uchida K, Matsudaira K (2025): Correlation between attention deficit/hyperactivity disorder and chronic pain: a survey of adults in Japan. Sci Rep. 2025 Apr 16;15(1):13165. doi: 10.1038/s41598-025-95864-4. PMID: 40240787; PMCID: PMC12003818. ↥
Stubbs B, Ma R, Solmi M, Veronese N, Van Damme T, Romano E, Stewart R, Mossaheb N, López-Gil JF, Firth J, Vancampfort D (2025): Chronic pain in mental disorders: An umbrella review of the prevalence, risk factors, and treatments across 957,168 people with mental disorders and 16,606,910 controls. Eur Psychiatry. 2025 Aug 12;68(1):e113. doi: 10.1192/j.eurpsy.2025.10074. PMID: 40790851; PMCID: PMC12438992. REVIEW ↥
Berggren SS, Bergman S, Almquist-Tangen G, Dahlgren J, Roswall J, Malmborg JS (2024): Frequent Pain is Common Among 10-11-Year-Old Children with Symptoms of Attention Deficit Hyperactivity Disorder. J Pain Res. 2024 Nov 19;17:3867-3879. doi: 10.2147/JPR.S472414. PMID: 39583198; PMCID: PMC11585263. n = 1.186 ↥
Battison EAJ, Brown PCM, Holley AL, Wilson AC (2023): Associations between Chronic Pain and Attention-Deficit Hyperactivity Disorder (ADHD) in Youth: A Scoping Review. Children (Basel). 2023 Jan 11;10(1):142. doi: 10.3390/children10010142. PMID: 36670692; PMCID: PMC9857366. REVIEW ↥ ↥
Chambers CT, Dol J, Tutelman PR, Langley CL, Parker JA, Cormier BT, Macfarlane GJ, Jones GT, Chapman D, Proudfoot N, Grant A, Marianayagam J (2024): The prevalence of chronic pain in children and adolescents: a systematic review update and meta-analysis. Pain. 2024 Oct 1;165(10):2215-2234. doi: 10.1097/j.pain.0000000000003267. PMID: 38743558; PMCID: PMC11404345. METASTUDY ↥ ↥ ↥
Udal ABH, Stray LL, Stray T, Bertelsen TB, Pripp AH, Egeland J (2024): ADHD-pain: Characteristics of chronic pain and association with muscular dysregulation in adults with ADHD. Scand J Pain. 2024 Sep 9;24(1). doi: 10.1515/sjpain-2024-0015. PMID: 39253953. ↥ ↥ ↥ ↥ ↥
King S, Chambers CT, Huguet A, MacNevin RC, McGrath PJ, Parker L, MacDonald AJ (2011): The epidemiology of chronic pain in children and adolescents revisited: a systematic review. Pain. 2011 Dec;152(12):2729-2738. doi: 10.1016/j.pain.2011.07.016. PMID: 22078064. ↥
Caverius U, Åkerblom S, Lexell J, Fischer MR (2025): Characteristics of Children With Persistent Pain and Their Parents in a Tertiary Interdisciplinary Pain Clinic. Paediatr Neonatal Pain. 2025 Apr 12;7(2):e70005. doi: 10.1002/pne2.70005. PMID: 40226841; PMCID: PMC11992596. ↥
Mundal I, Schei J, Lydersen S, Thomsen PH, Nøvik TS, Kvitland LR (2024): Prevalence of chronic and multisite pain in adolescents and young adults with ADHD: a comparative study between clinical and general population samples (the HUNT study). Eur Child Adolesc Psychiatry. 2024 May;33(5):1433-1442. doi: 10.1007/s00787-023-02249-x. PMID: 37386203; PMCID: PMC11098922. ↥ ↥
Asztély, Kopp, Gillberg, Waern, Bergman (2019): Chronic Pain And Health-Related Quality Of Life In Women With Autism And/Or ADHD: A Prospective Longitudinal Study. J Pain Res. 2019 Oct 18;12:2925-2932. doi: 10.2147/JPR.S212422. eCollection 2019. ↥ ↥ ↥
Kasahara S, Takahashi M, Suto T, Morita T, Obata H, Niwa SI (2025): Innovative therapeutic strategies using ADHD medications tailored to the behavioral characteristics of patients with chronic pain. Front Pharmacol. 2025 Feb 26;16:1500313. doi: 10.3389/fphar.2025.1500313. PMID: 40078279; PMCID: PMC11896983. REVIEW ↥
Pallanti S, Porta F, Salerno L (2021): Adult attention deficit hyperactivity disorder in patients with fibromyalgia syndrome: Assessment and disabilities. J Psychiatr Res. 2021 Apr;136:537-542. doi: 10.1016/j.jpsychires.2020.10.027. PMID: 33127072. n = 106 ↥
Kasahara S, Niwa SI, Matsudaira K, Sato N, Oka H, Fujii T, Konno SI, Kikuchi SI, Yamada Y (2021): High Attention-Deficit/Hyperactivity Disorder Scale Scores Among Patients with Persistent Chronic Nonspecific Low Back Pain. Pain Physician. 2021 May;24(3):E299-E307. PMID: 33988951. ↥ ↥
Kasahara S, Kato Y, Takahashi K, Matsudaira K, Sato N, Fukuda KI, Toyofuku A, Niwa SI, Uchida K (2023): Improvement in persistent idiopathic facial pain with comorbid ADHD using the combination of a dopamine system stabilizer and psychostimulant: A case report. Clin Case Rep. 2023 Jun 19;11(6):e7552. doi: 10.1002/ccr3.7552. PMID: 37346882; PMCID: PMC10279936. ↥
Takahashi K, Kasahara S, Takahashi M, Morita T, Sato N, Momose T, Matsudaira K, Niwa SI, Uchida K, Handa T, Ichinohe T, Fukuda KI (2025): Recognition and treatment of attention deficit-hyperactivity disorder in patients with treatment-resistant burning mouth syndrome: a retrospective case study. Front Pain Res (Lausanne). 2025 Apr 23;6:1536584. doi: 10.3389/fpain.2025.1536584. PMID: 40337528; PMCID: PMC12055801. ↥
Ciochetti NP, de Oliveira VF, Junger-Santos I, Bandeira CE, Tavares ME, Vitola ES, Rohde LA, de Andrade GM, da Silva BS, Grevet EH, Dotto Bau CH, Rovaris DL (2025): Genetic Interplay Between Attention-Deficit/Hyperactivity Disorder and Pain Suggests Neurodevelopmental Pathways and Comorbidity Risk. Biol Psychiatry Glob Open Sci. 2025 Apr 25;5(4):100517. doi: 10.1016/j.bpsgos.2025.100517. PMID: 40547906; PMCID: PMC12179596. ↥
Gee TA, Weintraub NC, Lu D, Phelps CE, Navratilova E, Heien ML, Porreca F (2020): A pain-induced tonic hypodopaminergic state augments phasic dopamine release in the nucleus accumbens. Pain. 2020 Oct;161(10):2376-2384. doi: 10.1097/j.pain.0000000000001925. PMID: 32453137; PMCID: PMC7508893. ↥
Taylor AMW, Becker S, Schweinhardt P, Cahill C (2016): Mesolimbic dopamine signaling in acute and chronic pain: implications for motivation, analgesia, and addiction. Pain. 2016 Jun;157(6):1194-1198. doi: 10.1097/j.pain.0000000000000494. PMID: 26797678; PMCID: PMC4866581. ↥ ↥
Tiemann L, Heitmann H, Schulz E, Baumkötter J, Ploner M (2014): Dopamine precursor depletion influences pain affect rather than pain sensation. PLoS One. 2014 Apr 23;9(4):e96167. doi: 10.1371/journal.pone.0096167. PMID: 24760082; PMCID: PMC3997524. ↥
Sifeddine W, Ba-M’hamed S, Landry M, Bennis M (2023): Effect of atomoxetine on ADHD-pain hypersensitization comorbidity in 6-OHDA lesioned mice. Pharmacol Rep. 2023 Feb 14. doi: 10.1007/s43440-023-00459-3. PMID: 36787018. ↥
Treister R, Eisenberg E, Demeter N, Pud D (2015): Alterations in pain response are partially reversed by methylphenidate (Ritalin) in adults with attention deficit hyperactivity disorder (ADHD). Pain Pract. 2015 Jan;15(1):4-11. doi: 10.1111/papr.12129. PMID: 24134430. ↥
Burkey AR, Carstens E, Jasmin L (1999): Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception. J Neurosci. 1999 May 15;19(10):4169-79. doi: 10.1523/JNEUROSCI.19-10-04169.1999. PMID: 10234044; PMCID: PMC6782709. ↥
Li J, Ji YP, Qiao JT, Dafny N (1992): Suppression of nociceptive responses in parafascicular neurons by stimulation of substantia nigra: an analysis of related inhibitory pathways. Brain Res. 1992 Sep 18;591(1):109-15. doi: 10.1016/0006-8993(92)90984-h. PMID: 1446222. ↥
Baumeister AA, Anticich TG, Hawkins MF, Liter JC, Thibodeaux HF, Guillory EC (1988): Evidence that the substantia nigra is a component of the endogenous pain suppression system in the rat. Brain Res. 1988 Apr 26;447(1):116-21. doi: 10.1016/0006-8993(88)90971-7. PMID: 3382946. ↥
Juri C, Rodriguez-Oroz M, Obeso JA (2010): The pathophysiological basis of sensory disturbances in Parkinson’s disease. J Neurol Sci. 2010 Feb 15;289(1-2):60-5. doi: 10.1016/j.jns.2009.08.018. PMID: 19758602. ↥
Treister R, Pud D, Ebstein RP, Laiba E, Gershon E, Haddad M, Eisenberg E (2009): Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy humans. Pain. 2009 Dec 15;147(1-3):187-93. doi: 10.1016/j.pain.2009.09.001. PMID: 19796878. ↥
Rosen AEV, Ursitti F, Stella N, Papetti L, Checchi MP, Voci A, Mazzone L, Valeriani M, Moavero R (2025): Restless legs syndrome and growing pains in childhood: understanding the link. Front Neurol. 2025 Aug 22;16:1603694. doi: 10.3389/fneur.2025.1603694. PMID: 40917655; PMCID: PMC12411773. REVIEW ↥
Kasahara S, Niwa SI, Matsudaira K, Sato N, Oka H, Yamada Y (2020): Attention-Deficit/Hyperactivity Disorder and Chronic Pain. Psychosom Med. 2020 Apr;82(3):346-347. doi: 10.1097/PSY.0000000000000789. PMID: 32251099. ↥
Stray, Kristensen, Lomeland, Skorstad, Stray, Tønnessen (2013): Motor regulation problems and pain in adults diagnosed with ADHD. Behav Brain Funct. 2013 May 3;9:18. doi: 10.1186/1744-9081-9-18. PMID: 23642255; PMCID: PMC3652792. ↥
Merzon E, Magen E, Levy Y, Ashkenazi S, Manor I, Weizman A, Krone B, Faraone SV, Green I, Golan-Cohen A, Vinker S, Israel A (2024): Pain-Associated Diagnoses in Childhood Before the Diagnosis of Attention-Deficit/Hyperactivity Disorder: A Population-Based Study. Children (Basel). 2024 Nov 15;11(11):1388. doi: 10.3390/children11111388. PMID: 39594963; PMCID: PMC11593160.. n = 56.268 ↥
Kasahara S, Takahashi K, Matsudaira K, Sato N, Fukuda KI, Toyofuku A, Yoshikawa T, Kato Y, Niwa SI, Uchida K (2023): Diagnosis and treatment of intractable idiopathic orofacial pain with attention-deficit/hyperactivity disorder. Sci Rep. 2023 Jan 30;13(1):1678. doi: 10.1038/s41598-023-28931-3. PMID: 36717626; PMCID: PMC9887013. ↥
Salem H, Vivas D, Cao F, Kazimi IF, Teixeira AL, Zeni CP (2018): ADHD is associated with migraine: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2018 Mar;27(3):267-277. doi: 10.1007/s00787-017-1045-4. PMID: 28905127. REVIEW ↥
Arruda MA, Arruda R, Guidetti V, Bigal ME (2020): ADHD Is Comorbid to Migraine in Childhood: A Population-Based Study. J Atten Disord. 2020 May;24(7):990-1001. doi: 10.1177/1087054717710767. PMID: 28587507. ↥ ↥
Arruda MA, Guidetti V, Galli F, Albuquerque RC, Bigal ME (2010): Migraine, tension-type headache, and attention-deficit/hyperactivity disorder in childhood: a population-based study. Postgrad Med. 2010 Sep;122(5):18-26. doi: 10.3810/pgm.2010.09.2197. PMID: 20861584. ↥
Fil A, Cano-de-la-Cuerda R, Muñoz-Hellín E, Vela L, Ramiro-González M, Fernández-de-Las-Peñas C (2013): Pain in Parkinson disease: a review of the literature. Parkinsonism Relat Disord. 2013 Mar;19(3):285-94; discussion 285. doi: 10.1016/j.parkreldis.2012.11.009. PMID: 23246139. ↥
Thompson T, Gallop K, Correll CU, Carvalho AF, Veronese N, Wright E, Stubbs B (2017): Pain perception in Parkinson’s disease: A systematic review and meta-analysis of experimental studies. Ageing Res Rev. 2017 May;35:74-86. doi: 10.1016/j.arr.2017.01.005. PMID: 28179128. ↥
Cury RG, Galhardoni R, Fonoff ET, Perez Lloret S, Dos Santos Ghilardi MG, Barbosa ER, Teixeira MJ, Ciampi de Andrade D (2016): Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms. Eur J Pain. 2016 Feb;20(2):151-65. doi: 10.1002/ejp.745. PMID: 26147660. ↥
Stubbs B, Thompson T, Acaster S, Vancampfort D, Gaughran F, Correll CU (2015): Decreased pain sensitivity among people with schizophrenia: a meta-analysis of experimental pain induction studies. Pain. 2015 Nov;156(11):2121-2131. doi: 10.1097/j.pain.0000000000000304. PMID: 26207650. METASTUDIE ↥
He X, Koibuchi I, Arai Y, Suto T, Hiroki T, Obata H, Saito S (2025): Gabapentin fails to provide analgesia while duloxetine remains effective in an attention deficit hyperactivity disorder rat model with neuropathic pain. Brain Res. 2025 Sep 15;1863:149811. doi: 10.1016/j.brainres.2025.149811. PMID: 40645535. ↥
Kasahara S, Niwa SI, Matsudaira K, Sato N, Oka H, Fujii T, Konno SI, Kikuchi SI, Yamada Y (2021): High Attention-Deficit/Hyperactivity Disorder Scale Scores Among Patients with Persistent Chronic Nonspecific Low Back Pain. Pain Physician. 2021 May;24(3):E299-E307. PMID: 33988951.}}) erklären in{{Udal ABH, Stray LL, Stray T, Bertelsen TB, Pripp AH, Egeland J (2024): ADHD-pain: Characteristics of chronic pain and association with muscular dysregulation in adults with ADHD. Scand J Pain. 2024 Sep 9;24(1). doi: 10.1515/sjpain-2024-0015. PMID: 39253953. ↥
Lakkadsha TM, Qureshi MI, Kovela RK, Saifee SS, Lalwani SS (2022): Efficacy of Single Stretching Session of Iliopsoas Using Proprioceptive Neuromuscular Facilitation Versus Muscle Energy Technique on Low Back Pain in Patients With Lumbar Hyper-Lordosis. Cureus. 2022 Aug 12;14(8):e27916. doi: 10.7759/cureus.27916. PMID: 36110466; PMCID: PMC9464355. ↥
García-Marín, Campos, Cuéllar-Partida, Medland, Kollins, Rentería (2021): Large-scale genetic investigation reveals genetic liability to multiple complex traits influencing a higher risk of ADHD. Sci Rep. 2021 Nov 19;11(1):22628. doi: 10.1038/s41598-021-01517-7. PMID: 34799595. ↥
Onda A, Onozato K, Kimura M (2022): Clinical features of neck and shoulder pain (Katakori) in Japanese hospital workers. Fukushima J Med Sci. 2022 Aug 18;68(2):79-87. doi: 10.5387/fms.2022-02. PMID: 35660659; PMCID: PMC9493333. n = 359 ↥
Stray (2009): Motor problems in Children with ADHD and clinical effects of Methylphenidate as assessed with the MFNU. Dissertation. ↥
Stray, Stray, Iversen, Ruud, Ellertsen (2009): Methylphenidate improves motor functions in children diagnosed with Hyperkinetic Disorder. Behav Brain Funct. 2009 May 13;5:21. doi: 10.1186/1744-9081-5-21. PMID: 19439096; PMCID: PMC2686715. ↥